Latest Advisory

  • FDA Advisory No. 2017-307 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 63)

    FDA Advisory No. 2017-307 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 63)

    Read more

  • FDA Advisory No. 2017-306 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 11)

    FDA Advisory No. 2017-306 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 11)

    Read more

  • FDA Advisory No. 2017-305 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 10)

    FDA Advisory No. 2017-305 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 10)

    Read more

  • FDA Advisory No. 2017-304 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 9)

    FDA Advisory No. 2017-304 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 9)

    Read more

  • FDA Advisory No. 2017-303 || Public Health Warning Against the Purchase and Consumption of the Following Unregistered Food Supplements Claiming to Contain L-Glutathione:

    FDA Advisory No. 2017-303 || Public Health Warning Against the Purchase and Consumption of the Following Unregistered Food Supplements Claiming to Contain L-Glutathione:

    Read more

  • FDA Advisory No. 2017-297 || Public Health Warning Against the Purchase and Consumption of the Following Unregistered Food Products and Food Supplements:

    FDA Advisory No. 2017-297 || Public Health Warning Against the Purchase and Consumption of the Following Unregistered Food Products and Food Supplements:

    Read more

  • FDA Advisory No. 2017-299 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 19)

    FDA Advisory No. 2017-299 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 19)

    Read more

  • FDA Advisory No. 2017- 296 || Public Health Warning Against the Use of Unnotified Toy and Childcare Article (TCCAs) Products (Batch 11)

    FDA Advisory No. 2017- 296 || Public Health Warning Against the Use of Unnotified Toy and Childcare Article (TCCAs) Products (Batch 11)

    Read more

  • FDA Advisory No. 2017-298 || Reiteration of FDA Advisory No. 2017-212 entitled “Public Health Warning Against the Purchase and Use of Unregistered Health Related Device (Water Purification Device) Biocera Alkaline Antioxidant Stick, FDA Advisory No. 2014-

    FDA Advisory No. 2017-298 || Reiteration of FDA Advisory No. 2017-212 entitled “Public Health Warning Against the Purchase and Use of Unregistered Health Related Device (Water Purification Device) Biocera Alkaline Antioxidant Stick, FDA Advisory No. 2014-

    Read more

  • FDA Advisory No. 2017- 301 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Supplements:

    FDA Advisory No. 2017- 301 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Supplements:

    Read more

  • FDA Advisory No. 2017-300 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products:

    FDA Advisory No. 2017-300 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products:

    Read more

  • FDA Advisory No. 2017-295 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 8)

    FDA Advisory No. 2017-295 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 8)

    Read more

  • FDA Advisory No. 2017-294 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 4)

    FDA Advisory No. 2017-294 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 4)

    Read more

  • FDA Advisory No. 2017-302 || RESULTS OF THE FOOD AND DRUG ADMINISTRATION’S (FDA) RE-EVALUATION OF CONTRACEPTIVE PRODUCTS FOR RECERTIFICATION

    FDA Advisory No. 2017-302 || RESULTS OF THE FOOD AND DRUG ADMINISTRATION’S (FDA) RE-EVALUATION OF CONTRACEPTIVE PRODUCTS FOR RECERTIFICATION

    Read more

  • FDA Advisory No. 2017-292 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 65)

    FDA Advisory No. 2017-292 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 65)

    Read more

  • FDA Advisory No. 2017-293 || Public Health Warning Against the Purchase and Consumption of the Following Unregistered Food Products and Food Supplements:

    FDA Advisory No. 2017-293 || Public Health Warning Against the Purchase and Consumption of the Following Unregistered Food Products and Food Supplements:

    Read more

  • FDA Advisory No. 2017-291 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 7)

    FDA Advisory No. 2017-291 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 7)

    Read more

  • FDA Advisory No. 2017-290-A || Paalala sa Publiko sa Pagbili at Paggamit ng mga Produktong Laruan Maaring Magdulot ng Kapahamakan sa Kalusugan

    FDA Advisory No. 2017-290-A || Paalala sa Publiko sa Pagbili at Paggamit ng mga Produktong Laruan Maaring Magdulot ng Kapahamakan sa Kalusugan

    Read more

  • FDA Advisory No. 2017-290 || Public Health Warning Against the Use and Purchase of Toy and Childcare Article (TCCAs) Products which are Hazardous to Health (Batch 2)

    FDA Advisory No. 2017-290 || Public Health Warning Against the Use and Purchase of Toy and Childcare Article (TCCAs) Products which are Hazardous to Health (Batch 2)

    Read more

  • FDA Advisory No. 2017-289 || Public Health Warning Against the Use of Unnotified Cosmetic Products Found to Contain Toxic Mercury (Hg) Levels (Batch 2)

    FDA Advisory No. 2017-289 || Public Health Warning Against the Use of Unnotified Cosmetic Products Found to Contain Toxic Mercury (Hg) Levels (Batch 2)

    Read more

FDA DG Opening Statement

DOH Press Conference

November 16, 2017

Good morning.

I am pleased and honored to join our Secretary of Health, the Honorable Francisco T. Duque III in today’s press conference.

At the outset, I would like to say that Secretary Duque’s acceptance of the health portfolio was well-timed and was a blessing to the FDA. In more ways than one, Secretary Duque’s guidance to, as well as his confidence and trust in the processes and procedures of the FDA, proved to be very valuable as the reevaluation and recertification process came to the homestretch.

For this, I would like to publicly express my gratitude to Secretary Duque on behalf of the scientists and the technical teams of the FDA.

Thank you, Mr. Secretary.

For the FDA’s part, we are happy to have done our part in making sure that the government’s Reproductive Health Program gets back on track.

We are happy that President Duterte has given us his full support in the task of recertifying the contraceptive products covered by a resolution of the Supreme Court.

The President’s trust and confidence enabled us to adhere to the highest standards of scientific and technical testing which, in turn, assures the public that the contraceptives recertified by the FDA are safe and are non-abortifacient.


We thank the President for helping us get our job done and done well.

Thank you everyone.

The Food and Drug Administration (FDA) announced that the technical review and reevaluation process of 51 contraceptive products covered by a resolution issued by the Supreme Court has been completed.

The FDA in an advisory, said that the 51 contraceptive products the agency evaluated for months have passed the strict requirements of the technical review and reevaluation process.

Having met the requirements and passed the standards, the FDA is now preparing the recertification of these products.

The recertification will attest to the safety of the products and that these have been determined to be NON-ABORTIFACIENT.

The complete list has been posted in the FDA website and social media accounts.

The FDA also thanked the various sectors which helped the agency ensure that the recertification process is participative and transparent even as we adhered strictly to the methods of science in undertaking this task

DOH-FDA Healthcare Forum on Biotechnology

In line with the celebration of the 13th National Biotech Week, the Department of Health through the Food and Drug Administration will be conducting a Healthcare Forum on Biotechnology on 23 November 2017, 8:00 AM – 12:30 PM at the 4th Floor Conference Hall, National Meat Inspection Service, BAI Compound Visayas Ave, Vasra Diliman, Quezon City, 1128 Metro Manila.

Mark your calendars, stakeholders and consumers are invited.

Admission is free!

Attachments:
Download this file (social-media-post.jpg)social-media-post.jpg

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter